We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Cost-Sharing for Prescription Drugs—Reply

Robyn Tamblyn, PhD; Michal Abrahamowicz, PhD; Jim Hanley, PhD; Nancy Mayo, PhD; Jerry Hurley, PhD
JAMA. 2001;285(18):2328-2329. doi:10.1001/jama.285.18.2328.
Text Size: A A A
Published online


In Reply: We agree with Ms Gibson and colleagues that one must be cautious in generalizing study results to different populations. However, one cannot compare their results with ours and conclude that their data provide evidence that the employed, unlike the poor and elderly, are only transiently affected by prescription cost-sharing. Methodological differences in the approaches taken may have contributed to apparent differences in findings. Our study measured the response to the policy implementation for each person in the study population, whereas the analysis by Gibson et al appears to have used an aggregate measure of prescription consumption for the study population in each quarter. When the underlying population remains constant, results for these 2 forms of analysis should be similar; however, this assumption requires validation. In the results of Gibson et al, the almost flat rate of consumption in the first 7 quarters preceding the co-payment policy followed by variation in utilization rates of 25% in the next 8 quarters suggests that other factors, including a possible change in the underlying population, may have been operative. This could bias the evaluation of the policy change because drug consumption is being compared among different groups.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.